Acute nephrotoxicity of cisplatin: molecular mechanisms.

The nephrotoxic drugs have been responsible for about 20% of AKI episodes in inpatients and outpatients. The cisplatin nephrotoxicity is a major limiting factors in 20% of patients who have received the drug, triggering injuries in renal tubular epithelial cells. Cisplatin toxicity is determined by the target tissue and cells accumulation besides the interaction with various subcellular structures and macromolecules. Cisplatin accumulates and interferes with the functioning of different organelles such as mitochondria, lysosomes, endoplasmic reticulum, nuclei and cell membranes, causing inflammation and cell death. This review aims to define the pathophysiology and biochemistry of the cisplatin nephrotoxicity, reviewing the main molecular mechanisms that lead to tubular cisplatin toxicity.

[1]  M. Kuhlmann,et al.  Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  L. Truong,et al.  Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. , 2000, American journal of physiology. Renal physiology.

[3]  A. Lichtenstein,et al.  Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines , 2000, Cancer Chemotherapy and Pharmacology.

[4]  J. Megyesi,et al.  Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure. , 2002, Kidney international.

[5]  J. Megyesi,et al.  Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure , 2002 .

[6]  M. Hanigan,et al.  Role of Cysteine S-Conjugate β-Lyase in the Metabolism of Cisplatin , 2003, Journal of Pharmacology and Experimental Therapeutics.

[7]  G. Ramesh,et al.  TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. , 2003, American journal of physiology. Renal physiology.

[8]  Hua Liu,et al.  Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. , 2003, Kidney international.

[9]  M. Hanigan,et al.  Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin. , 2003, The Journal of pharmacology and experimental therapeutics.

[10]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[11]  H. Hansen,et al.  Magnesium depletion enhances cisplatin-induced nephrotoxicity. , 2005, Cancer Chemotherapy and Pharmacology.

[12]  G. Ramesh,et al.  p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. , 2005, American journal of physiology. Renal physiology.

[13]  M. Razzaque,et al.  Cisplatin-associated nephrotoxicity and pathological events. , 2005, Contributions to nephrology.

[14]  R. Çetin,et al.  Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods , 2006, Journal of applied toxicology : JAT.

[15]  C. Green,et al.  Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. , 2006, American journal of physiology. Renal physiology.

[16]  A. C. Santos,et al.  Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria , 2007, Archives of Toxicology.

[17]  G. Dong,et al.  Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. , 2007, Biochemical pharmacology.

[18]  A. C. Santos,et al.  Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria , 2007, Cancer Chemotherapy and Pharmacology.

[19]  Celia Quevedo,et al.  Biochemical mechanisms of cisplatin cytotoxicity. , 2007, Anti-cancer agents in medicinal chemistry.

[20]  Zhongmin Guo,et al.  Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer , 2007, Journal of bioenergetics and biomembranes.

[21]  G. Ramesh,et al.  Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. , 2007, Kidney international.

[22]  Z. Dong,et al.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. , 2008, Kidney international.

[23]  J. Pedraza-Chaverri,et al.  Selective iNOS inhibition reduces renal damage induced by cisplatin. , 2008, Toxicology letters.

[24]  Cynthia A. Naughton,et al.  Drug-induced nephrotoxicity , 1984 .

[25]  R. Weaver,et al.  Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. , 2008, Toxicology.

[26]  S. Akira,et al.  TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. , 2008, Journal of the American Society of Nephrology : JASN.

[27]  Man Jiang,et al.  Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity , 2008, Journal of Pharmacology and Experimental Therapeutics.

[28]  H. Koepsell,et al.  Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. , 2010, The American journal of pathology.

[29]  G. Ramesh,et al.  Mechanisms of Cisplatin Nephrotoxicity , 2010, Toxins.

[30]  J. Klawitter,et al.  Biomarkers of Acute Kidney Injury , 2011, Journal of toxicology.

[31]  J. López-Novoa,et al.  An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity , 2011, Critical reviews in toxicology.

[32]  J. López-Novoa,et al.  Subcellular targets of cisplatin cytotoxicity: an integrated view. , 2012, Pharmacology & therapeutics.

[33]  J. Joseph,et al.  Mitochondrial‐targeted antioxidants represent a promising approach for prevention of cisplatin‐induced nephropathy , 2012, Free radical biology & medicine.

[34]  A. C. Santos,et al.  Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update , 2012, Archives of Toxicology.